TABLE 2

Gene expression in HepaRG cells as a function of time at confluence

Comparative expression of various genes in differentiated HepaRG cells at several confluent time points. Results are expressed as percentages compared with day 30 after seeding, arbitrary set at 100%, and are the mean ± S.E.M. of three independent experiments. In parentheses are the percentages of the values measured in a pool of freshly isolated human hepatocytes from three donors.


Genes

mRNA Levels (%)
30
37
44
51
58
p
days
Aldolase B 100 (6) 113 ± 14 129 ± 38 155 ± 36 154 ± 28 N.S.
CYP3A4 100 (119) 99 ± 11 108 ± 47 111 ± 31 105 ± 15 N.S.
CYP1A2 100 (1) 111 ± 35 128 ± 25 109 ± 42 93 ± 38 N.S.
CYP2B6 100 (32) 117 ± 12 185 ± 9 181 ± 24 208 ± 71 N.S.
CYP2E1 100 (5) 207 ± 38 187 ± 13 169 ± 38 133 ± 16 N.S.
GSTA1/2 100 (186) 90 ± 15 89 ± 18 106 ± 15 94 ± 10 N.S.
UGT1A1 100 (181) 81 ± 8 96 ± 11 90 ± 3 81 ± 19 N.S.
mEH 100 (213) 101 ± 10 105 ± 3 111 ± 13 114 ± 16 N.S.
BSEP 100 (2) 93 ± 36 150 ± 84 181 ± 55 233 ± 37 N.S.
MDR1 100 (303) 81 ± 10 89 ± 3 71 ± 9 72 ± 12 N.S.
OCT1 100 (25) 124 ± 25 159 ± 20 181 ± 12 173 ± 26 N.S.
MRP2 100 (164) 112 ± 9 133 ± 4 116 ± 11 117 ± 22 N.S.
CAR 100 (21) 111 ± 4 143 ± 47 143 ± 26 136 ± 14 N.S.
PXR 100 (58) 132 ± 23 172 ± 32 176 ± 28 188 ± 59 N.S.
MnSOD 100 (317) 105 ± 17 145 ± 10 144 ± 22 121 ± 31 N.S.
Catalase
100 (67)
84 ± 2
100 ± 20
88 ± 16
89 ± 18
N.S.
  • N.S., not statistically significant.